Median Survival Rate Nearly Doubles Combining Inotuzumab with Chemotherapy

Median Survival Rate Nearly Doubles Combining Inotuzumab with Chemotherapy

Cancer-News

2 years
542 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Hagop M. Kantarjian, MD of MD Anderson Cancer Center's Department of Leukemia states the
median survival rate nearly doubles combining Inotuzumab with chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Up Next Autoplay